• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 15, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2133-12
Classification Class III
Code Info 3270188347, 3270187833, 3270186174, 3270185904, 3270184947, 3270209668, 3270209101, 3270208775, 3270208200, 3270207880, 3270207303, 3270206968, 3270206410, 3270206106, 3270205543, 3270205233, 3270204604, 3270204322, 3270203751, 3270203417, 3270202882, 3270202560, 3270202006, 3270201709, 3270201150, 3270200829, 3270200273, 3270199969, 3270199389, 3270199089, 3270198499, 3270198181, 3270197543, 3270197188, 3270196532, 3270196114, 3270195019, 3270194450, 3270193990, 3270193500, 3270191564, 3270190082, 3270188723, 3270187148, 3270185258, 3270192964, 3270192093, 3270191039, 3270190592, 3270189609, 3270189148
Product Distributed Qty 51 units
Reason For Recall Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.

Event Detail

Event Id 62356
Product Type Biologics
Status Terminated
Recalling Firm Talecris Plasma Resources, Inc.
City Indianapolis
State IN
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-05-26
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern North Carolina
-
-